首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >RES529, A DUAL TORC1/TORC2 INHIBITOR, POTENTIATES THE IN VITRO AND IN VIVO EFFICACY OF HORMONE MANIPULATIONS IN THE 22RV1 PROSTATE CANCER CELL MODEL

【24h】

RES529, A DUAL TORC1/TORC2 INHIBITOR, POTENTIATES THE IN VITRO AND IN VIVO EFFICACY OF HORMONE MANIPULATIONS IN THE 22RV1 PROSTATE CANCER CELL MODEL

机译：RES529是一种双TORC1 / TORC2抑制剂，可增强22RV1前列腺癌细胞模型中激素操纵的体外和体内功效。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Anticancer Research: International Journal of Cancer Research and Treatment》 |2015年第6期|共2页
作者
Gravina Giovanni Luca; Marampon Francesco; Colapietro Alessandro; Scarsella Luca; Jitariuc Ana; Sanita Patrizia; Sherris David; Festuccia Claudio;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. RES529, A DUAL TORC1/TORC2 INHIBITOR, POTENTIATES THE IN VITRO AND IN VIVO EFFICACY OF HORMONE MANIPULATIONS IN THE 22RV1 PROSTATE CANCER CELL MODEL [J] . Gravina Giovanni Luca, Marampon Francesco, Colapietro Alessandro, Anticancer Research: International Journal of Cancer Research and Treatment . 2015,第6期

机译：RES529是一种双TORC1 / TORC2抑制剂，可增强22RV1前列腺癌细胞模型中激素操纵的体外和体内功效。
2. The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells [J] . Giovanni Luca Gravina^12, Francesco Marampon^12, Foteini Petini^1, Endocrine-related cancer . 2011,第4期

机译：TORC1 / TORC2抑制剂Palomid 529可降低侵袭性和激素难治性前列腺癌细胞的肿瘤生长并对多西他赛和顺铂敏感
3. Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity [J] . SyedF., SanganeeH.J., BahlA., The Journal of investigative dermatology. . 2013,第5期

机译：有效的TORC1和TORC2复合物双重抑制剂（KU-0063794和KU-0068650）表现出体外和离体抗瘢痕loid疤痕活性
4. Design, Synthesis, Biophysical and Structure-Activity Properties of a Novel Dual MDM2 and MDMX Targeting Stapled α-Helical Peptide: ATSP-7041 Exhibits Potent In Vitro and In Vivo Efficacy in Xenograft Models of Human Cancer [C] . V. Guerlavais, K. Darlak, B. Graves American Peptide Symposium . 2013

机译：新型双MDM2和MDMX靶向吻合α-螺旋肽的设计，合成，生物物理和结构 - 活性特性：ATSP-7041在体外表现出效率和体内人类癌症的模型
5. Pterostilbene Combined with Histone Deacetylase Inhibitor Attenuates Prostate Cancer Progression In Vitro and In Vivo [D] . Butt, Nasir A. 2017

机译：蝶呤与组蛋白脱乙酰基酶抑制剂组合可减轻前列腺癌的体内和体外进展。
6. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor RES529 Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models [O] . Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, 2019

机译：脑穿透和双重TORC1 / TORC2抑制剂RES529激发抗神经胶质瘤活性并增强临床前小鼠模型中抗血管生成化合物的治疗作用
7. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models [O] . Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, 2019

机译：脑穿透和双TORC1 / TORC2抑制剂，RES529，引发抗胶质瘤活性并增强抗血管生成化合物在临床前鼠模型的治疗效果

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号